clinical trial Archives
Oct. 27, 2016—In 2011, doctors at the Vanderbilt Heart and Vascular Institute performed the state’s first transcatheter valve-replacement (TAVR) procedure for high-risk patients suffering from aortic stenosis, the most common valvular heart disease in the United States.
Oct. 20, 2016—Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis.
Vanderbilt establishes Recruitment Innovation Center to increase enrollment of minorities, women and older adults in clinical trials
Jul. 5, 2016—Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this.
Apr. 14, 2016—This month an international HIV prevention trial was launched that is testing the infection-preventing prowess of a monoclonal antibody called VRCO1.
Feb. 23, 2016—Among doctors, it is widely believed that a class of drugs called statins, which are used to lower cholesterol, might help patients tolerate the stress of cardiac surgery. Not so, according to a five-year, placebo-controlled, double-blinded randomized clinical trial conducted at Vanderbilt University Medical Center, published today in the Journal of the American Medical Association....
Nov. 5, 2015—An initiative promoted by the Vanderbilt Institute of Clinical and Translational Research (VICTR) offers an opportunity to reduce by more than half the time it takes to negotiate clinical trial contracts.
Sep. 10, 2015—Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment.
Feb. 25, 2015—Vanderbilt University Medical Center is participating in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital. Randomized patients who are at risk of hemorrhaging could receive two units of plasma, which can improve a patient’s...
Feb. 12, 2015—Pertussis, commonly known as whooping cough, is experiencing a resurgence, and its tiniest victims are not armed to battle the contagious respiratory infection.
Apr. 3, 2014—A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial.
Nov. 14, 2013—Vanderbilt Heart and Vascular Institute is participating in a clinical trial to evaluate a medical device for the treatment of coronary artery disease.